News
Immunocore Holdings' stock has dropped 60% as Kimmtrak faces market saturation, but its pipeline could offer potential. Find ...
Download your copy now and drive the future of CAR-T and TCR therapies. Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we ...
3h
Top Gear on MSNVW won at the Nürburgring in '24, but it nearly didn't happen: here's the story behind the attemptUse precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
12don MSN
A team of researchers has successfully created more effective immune cells that can fight cancer without damaging healthy ...
but rather T-Cell receptors (TCRs)). At CAR-TCR, many of the most anticipated presentations were about the move to solid tumours, where a hostile tumour micro-environment is one of the primary ...
Team Clairet Sport's Jimmy Clairet believes luck was on his side on the opening TCR Europe weekend of the year at Portimão, ...
The entry list for the opening rounds of the new TCR World Tour season has been confirmed, with a field of 24 cars set to ...
If preclinical findings were translated into the clinic, they could shorten the CAR-T generation lead time from two weeks to ...
The Mk7 Volkswagen Golf GTI wasn’t long for this world when the GTI TCR (Touring Car Racing) came along, with the final GTIs being short-run specials. As we were driving the Golf GTI TCR ...
IMA203 is an autologous, engineered T-cell receptor T-cell therapy (TCR T) that targets PRAME, an intracellular protein displayed as a peptide antigen on the surface of multiple solid tumors via ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results